Related Experiment Videos
Early cellular events in systemic autoimmunity driven by chromatin-reactive T cells
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, 92121, USA.
Cellular Immunology
|May 3, 2001
Summary
Lupus-inducing drugs generate chromatin-reactive T cells. These T cells drive autoreactive B cells to produce anti-chromatin antibodies, especially when Fas-mediated cell death is inhibited, revealing a pathway for autoimmunity.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Exposure to lupus-inducing drugs like procainamide-hydroxylamine triggers T cell responses against chromatin.
- The origin and role of autoantibodies in drug-induced lupus remain unclear.
- Understanding B cell responses to T cells is crucial for elucidating autoimmune initiation.
Purpose of the Study:
- To identify the specificities of B cells responding to chromatin-reactive T cells.
- To investigate the role of Fas-mediated cell death in the expansion of autoreactive B cells.
- To determine if B cells can present chromatin-bound antigens to T cells.
Main Methods:
- Adoptive transfer of chromatin-reactive T cells into mice.
- Quantification of IgM and IgG anti-chromatin antibody-secreting B cells.
- Assessment of B cell antigen presentation capabilities in vitro.
- Analysis of B cell responses in mice with defective Fas (lpr allele).
Main Results:
- Adoptive transfer of chromatin-reactive T cells led to the emergence of IgM anti-chromatin B cells.
- B cell populations secreting anti-chromatin antibodies expanded significantly in mice with defective Fas.
- B cells could internalize DNA-bound proteins and present T cell epitopes.
- No direct binding of chromatin to anti-DNA antibodies was observed.
Conclusions:
- The study reveals that the immune system harbors autoreactive B cells capable of responding to T cell activation.
- Inhibition of Fas-mediated activation-induced cell death promotes the expansion of these autoreactive B cells.
- This highlights a potential mechanism for the development of autoimmunity, particularly in conditions like drug-induced lupus.